- Home >
- Clinicals Trials >
- ALCYTA (IC 2020-12)
Retour à la liste des essais cliniques
ALCYTA (IC 2020-12)
Exploration of Adaptive Antitumoral Immune Cells Through Leukapheresis in Cancer Patients: ALCYTA
- Ouvert à Paris depuis le : 09/06/2022
- Ouvert à Saint-Cloud depuis le : 09/06/2022
- Public cible : Adult
- Phase : Clinical trial
Description de l'essai
The study will evaluate the detection of tumor-antigen specific immune cells in cancer patients in whom the role of the immune system is suspected.
Url of the trialInvestigateur principal
